The BioCardia delivery catheter was designed to be used by interventional cardiologists, electrophysiologists or cardiac surgeons. It includes a tiny needle that directly engages with the patient’s cardiac tissue. 

The FDA has announced seven Class I recalls related to this issue. Customers are urged to destroy the devices immediately instead of returning them to the manufacturer. 

For years, the ECG market was relatively static. According to a new report, however, things are rapidly changing. 

HRS has shared an updated guidance on managing Boston Scientific defibrillation leads at risk of experiencing a significant malfunction. The issue, first reported in July 2025, is believed to impact approximately 350,000 leads still being used today.

AF Symposium 2026 in Boston included new data from some of the biggest names in electrophysiology. Johnson & Johnson MedTech, Abbott, Atraverse Medical, Field Medical, Pulse Biosciences, Argá Medtech SA and CardioFocus were just some of the medtech companies at the heart of late-breaking presentations. 

New drug allows patients to self-treat PSVT. About 2 million people in the U.S. have been diagnosed with condition.

eMurmer's new Heart AI software was designed to detect both the presence and absence of heart murmurs in digital stethoscope recordings. It can also gather critical hemodynamic data, helping care teams gain a better understanding of the patient's cardiovascular health. 

The all-in-one mapping and single-shot PFA catheter was developed with electrophysiologist feedback in mind.